CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 9 enrolled
Drug / intervention
Low Dose Naltrexonedrug
Likely dose
Low Dose Naltrexone 4.5 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02107014
NCT02107014N/ACompleted
CompareCT.gov

Low Dose Naltrexone (LDN) Immune Monitoring

University of Alabama at Birmingham·interventional·Posted Apr 8, 2014·Updated Apr 11, 2017

In Brief

A clinical study evaluating Low Dose Naltrexone for Fibromyalgia. Completed, enrolled 9 participants across 1 site.

Detailed Summary

We have found that low dose naltrexone (LDN) can substantially reduce pain associated with fibromyalgia syndrome. We believe LDN may work via novel anti-inflammatory channels. The purpose of this study is to determine if LDN lowers inflammatory markers in individuals with fibromyalgia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFibromyalgia
CountriesUnited States
CollaboratorsStanford University

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 8, 2014
Enrollment StartMar 1, 2014
Primary CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 12.2 years ago

Interventions

Low Dose Naltrexonedrug

Naltrexone 4.5 mg p.o. nocte